Holmium-166 transarterial radioembolization

· Terumo Europe N.V.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Holmium-166 transarterial radioembolization, covering 2025-08-26 to 2026-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer Patients [Phase 2]